Basic information
Biomarker: SOD
Histology type: endometrial carcinoma
Cohort characteristics
Country: Serbia
Region: Belgrade
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
98 | adenocarcinoma endometrii stage I | 5 | hyperplasia complex endometrii | 22 | hyperplasia simplex endometrii | 31 | healthy control patients | 45 |
Sample information
Conclusion: Since evidence suggests that SOD may be a therapy target for cancer treatment, our findings provide a basis for further research and options for clinical applications.
Sample type : serum
Sample method: SOD ACTIVITY ASSAY/LIPID HYDROPEROXIDES/WESTERN BLOTTING
Expression pattern : expression
Expression elevation: The SOD activity is determined from the ratio of the autoxidation rates in the presence (Vs) and absence (Vc) of SOD.
Disease information
Related information
UniProt Link: https://www.uniprot.org/uniprotkb?query=SOD
Molecular function from UniProt:
HPA link: https://www.proteinatlas.org/search/SOD
HGNC link: https://www.genenames.org/tools/search/#!/?query=SOD